Frequently Asked Questions
The market is segmented based on , By Diagnosis (Electrocardiogram, Echocardiogram, Stress Test, Cardiac catheterization, Heart CT Scan, Others) Treatment (Medication, Surgery, Additional Therapy, Others), End Users (Hospitals, Specialty Clinics, Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) - Industry Trends and Forecast to 2030.
.
The Global Coronary Artery Disease Market size was valued at USD 22943.21 USD Million in 2022.
The Global Coronary Artery Disease Market is projected to grow at a CAGR of 8.86% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer , Amgen , Cytokinetics, Hikma Pharmaceutical PLC, AbbVie , Lupin, Wockhardt, GLENMARK PHARMACEUTICAL LTD, Zydus Pharmaceutical , Amneal Pharmaceuticals LLC, Accord Healthcare, Aurobindo Pharma, LG Chem.
The market report covers data from the U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)..
